The focus of research in pancreatic cancer has mainly been in the metastatic setting, explains O’Reilly. There will be a rise in the incidence of pancreatic cancer making early detection an important area of study. There have been some early hints of the ability to identify who might be at risk. View here . . .
Eileen O’Reilly, MD, associate director for clinical research at Memorial Sloan Kettering Cancer Center discusses areas of research for patients with pancreatic cancer.